Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00694512 · ClinicalTrials.gov registry record · NA

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

A NA study of Obesity, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
51
Enrollment target
1
Study location

NCT00694512: Completed NA study of Obesity, sponsored by Oregon Health and Science University.

NCT00694512 is a NA study of Obesity that has completed, run by Oregon Health and Science University. The registered enrollment target is 51 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00694512, a NA study of Obesity, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Low fat diet
  • DIETARY_SUPPLEMENT High fat diet
  • DIETARY_SUPPLEMENT MCT diet

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2008-02
Est. Completion 2011-03
Phase NA

What the finished NCT00694512 record still lists

NCT00694512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Low fat diet is the first listed.

NCT00694512 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT00694512 about?

NCT00694512 is a clinical study titled "Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin". The purpose of this study is to learn more about how diet affects the hormone ghrelin. Ghrelin is made in the stomach and causes appetite to increase. Learning about ghrelin will help the investigators understand more about obesity.

What is the current status of trial NCT00694512?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2008-02. Estimated completion is 2011-03.

What conditions does trial NCT00694512 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00694512?

The interventions under investigation include: Low fat diet (DIETARY_SUPPLEMENT), High fat diet (DIETARY_SUPPLEMENT), MCT diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00694512?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00694512 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00694512's enrollment target sits among peer trials

51 709th of 1053 higher than 341 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00694512, the US trial registry maintained by the National Library of Medicine. NCT00694512 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.